Reviva Pharmaceuticals Holdings Inc. Warrants (25/12/2025) RVPHW 深 滬
等待開盤 03-26 09:30:00 美东时间
0.003
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 0.003
- 總市值 2.77万
- 52周最高 0.3678
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 0.003
- 委 比 0.00%
- 總股本 923.17万
- 歷史最高 3.00
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.003
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多What's Behind The Drop In Reviva Pharmaceuticals Stock?
Reviva Pharmaceuticals shares are tumbling Thursday after pricing a $10 million public offering of over 6 million shares at $1.50 per share.
03-20 00:49
BUZZ-U.S. STOCKS ON THE MOVE-Rivian, Biohaven, CervoMed
BUZZ-U.S. STOCKS ON THE MOVE-Rivian, Biohaven, CervoMed Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 March 19 (Reuters) - Wall Street's main indexes were set to open lower on
03-19 21:15
BUZZ-Reviva Pharma plunges on highly dilutive stock-and-warrants offering
BUZZ-Reviva Pharma plunges on highly dilutive stock-and-warrants offering ** Reviva Pharmaceuticals RVPH.O shares plunging 45% to record low $1.03 premarket after follow-on offering priced ** RVPH late Weds sold ~6.7 mln shares along with two series of accompanying warrants at $1.50 for $10 mln gros
03-19 19:44
BRIEF-Reviva Pharmaceuticals Announces Pricing Of $10 Million Public Offering At $1.50 Per Share
BRIEF-Reviva Pharmaceuticals Announces Pricing Of $10 Million Public Offering At $1.50 Per Share March 18 (Reuters) - Reviva Pharmaceuticals Holdings Inc RVPH.O : REVIVA PHARMACEUTICALS HOLDINGS, INC. ANNOUNCES PRICING OF $10 MILLION PUBLIC OFFERING REVIVA PHARMACEUTICALS HOLDINGS INC - PRICES PUBLI
03-19 10:35
Reviva Pharmaceuticals Holdings shares are trading lower after the company announced a proposed public offering.
Reviva Pharmaceuticals Holdings shares are trading lower after the company anno...
03-19 04:17
Reviva Pharmaceuticals Commences Common Stock Offering; Terms Undisclosed
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system
03-19 04:11
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
Reviva Pharmaceuticals Holdings, Inc. plans to offer shares of its common stock and warrants in a public offering to fund research and development activities, including its RECOVER-2 Phase 3 trial for brilaroxazine in schizophrenia, as well as for working capital and general corporate purposes. A.G.P./Alliance Global Partners is acting as the sole placement agent. The offering is subject to market conditions and SEC approval. Proceeds will also s...
03-18 20:10
D. Boral Capital Downgrades Reviva Pharmaceuticals to Hold
D. Boral Capital analyst Jason Kolbert downgrades Reviva Pharmaceuticals (NASDAQ:RVPH) from Buy to Hold.
03-06 05:39
Reviva Pharmaceuticals Announces One-for-Twenty Reverse Stock Split
An announcement from Reviva Pharmaceuticals Holdings ( ($RVPH) ) is now availab...
03-05 21:53
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05
